Tamás Révész

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

Catriona Parker, Rachel Waters, Carly Leighton et al. · The Lancet · 2010 · 335 citations · Full text

Medicine, Oncology, Pediatrics +14

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

Julie Irving, Amir Enshaei, Catriona Parker et al. · Blood · 2016 · 135 citations · Full text

Medicine, Genetics, Oncology +9

Persistent <scp>MRD</scp> before and after allogeneic <scp>BMT</scp> predicts relapse in children with acute lymphoblastic leukaemia

Rosemary Sutton, Peter J. Shaw, Nicola C. Venn et al. · British Journal of Haematology · 2014 · 75 citations · Full text

Medicine, Hematology, Pediatrics +17

Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials

Cornelia Eckert, Catriona Parker, Anthony V. Moorman et al. · European Journal of Cancer · 2021 · 66 citations · Full text

Medicine, Hematology, Oncology +17

High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation

Glenn M. Marshall, Luciano Dalla Pozza, Rosemary Sutton et al. · Leukemia · 2013 · 63 citations · Full text

Medicine, Oncology, Pediatrics +16